Salute e Benessere
Stroke Diagnostics Market Size to Hit USD 5.32 Bn By 2031
:
The rising incidence of stroke around the world is a major factor driving the growth of the stroke diagnostics market. According to WHO, 15 million people suffer from stroke worldwide each year. Furthermore, advancements in diagnostic imaging technologies for stroke diagnosis are also boosting the market growth. Computed tomography (CT) scan and magnetic resonance imaging (MRI) have revolutionized stroke diagnosis by detecting occlusions and bleed with high accuracy. Moreover, rising consumer awareness about early diagnosis of stroke is another driver of the market.
https://www.coherentmarketinsights.com/insight/request-sample/6794
:
Advanced imaging modalities such as CT scan, MRI, ultrasound, and positron emission tomography (PET) have gained widespread acceptance in stroke diagnosis in recent years. CT scan is predominantly used as the first-line imaging technique for acute stroke cases for detecting hemorrhage. Moreover, the ability of MRI to detect acute ischemic changes prior to infarction establishes it as a valuable secondary option in acute stroke evaluation.
Significant efforts are being made to develop specific and sensitive biomarkers that can aid early diagnosis and help distinguish between ischemic and hemorrhagic stroke. Some of the emerging biomarkers being explored for stroke diagnosis are S100 calcium binding protein B, glial fibrillary acidic protein, neuron-specific enolase, and myelin basic protein. Availability of such accurate biomarkers can transform stroke management.
Ischemic stroke accounts for nearly 87% of all stroke cases globally. Rising prevalence of cardiovascular diseases, obesity and diabetes are major risk factors driving the growth of ischemic strokes. Advancements in computed tomography (CT) and magnetic resonance imaging (MRI) technologies have enabled early detection and diagnosis of ischemic strokes. CT scans allow visualization of blood clots blocking arteries supplying blood to the brain. Similarly, MRI provides high resolution images to detect minute changes in the brain after an ischemic stroke. The ability of these imaging modalities to differentiate between ischemic and hemorrhagic strokes at an early stage is expected to support the growth of this segment during the forecast period.
Computerized tomography (CT) scan is the most widely used initial imaging test for diagnosis of acute stroke within the golden 3-hour window. CT scans provide rapid results within minutes and help determine if the stroke is caused by blockage of an artery or bleeding in the brain. Advances such as CT angiography allow visualization of blood vessels and arteries. Growing preference for CT scans as the preferred first-line diagnosis modality is expected to drive the computerized tomography segment. Meanwhile, improved MRI technologies with high resolution and ability to reveal microscopic changes are increasing the adoption of MRI for long-term stroke monitoring and research.
https://www.coherentmarketinsights.com/insight/request-customization/6794
:
In December 2023 , Siemens Healthnieers, unveiled the cutting-edge NAEOTOM Alpha, a huge forward in diagnostic imaging.
In October 2023 , Brainomix Ltd, and Nanoflex Robotics AG received a grant under the UKN Switzerland Bilateral: Collaborative R&D program.
:
The global stroke diagnostics market is anticipated to witness a CAGR of 8.1% during the forecast period 2024-2031, driven by rising geriatric population, growing incidence of hypertension and diabetes leading to strokes. On the basis of stroke type, the ischemic stroke segment is expected to hold a dominant position, accounting for nearly 87% of all stroke cases globally. By imaging test type, the computerized tomography scan segment is expected to hold the leading market share owing to rapid results and ability to determine clot location within the golden 3-hour window for thrombolysis.
On the basis of end user, hospitals are likely to remain the major revenue generator due to availability of advanced imaging facilities and dedicated stroke units. Regionally, North America is expected to dominate the global stroke diagnostics market through the forecast period due to high awareness levels, availability of advanced healthcare facilities and presence of key market players. Some of the leading players operating in the stroke diagnostics market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical System Corporation, Hitachi Medical Systems, Fujifilm Medical System, Samsung Medison among others. Collaborations for development of innovative diagnostic solutions is a key focus area for market players.
https://www.coherentmarketinsights.com/insight/buy-now/6794
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan : +81-050-5539-1737
India : +91-848-285-0837
sales@coherentmarketinsights.com
https://www.coherentmarketinsights.com
LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/stroke-diagnostics-market-size-to-hit-usd-5-32-bn-by-2031--302156748.html